Zotefoams (ZTF)

Sector:

Industrial Chemicals

Index:

FTSE Small Cap

400.00p
   
  • Change Today:
    -8.00p
  • 52 Week High: 494.00
  • 52 Week Low: 360.00
  • Currency: UK Pounds
  • Shares Issued: 48.62m
  • Volume: 7,883
  • Market Cap: £194.48m
  • RiskGrade: 186

Hikma Pharmaceuticals non-exec sells 5,700 shares

Date: Tuesday 21 May 2013

LONDON (ShareCast) - Ronald Goode, a non-Executive Director of Hikma Pharmaceuticals, has disposed of 5,700 shares at 983.00p each.

The £56,031 sale comes less than a week after the company upgraded its 2013 revenue growth forecast following a strong start to the year.

In an announcment released May 16th, the group told investors it expects revenue to rise 13% this year, up from its previous guidance of 10%, driven by the performance of Branded and Injectables and Generics businesses in the year-to-date.

The Branded and Injectables unit is on track to meet the firm’s full-year guidance, while the Generics arm is continuing to benefit from its doxycycline product which is delivering revenue ahead of forecasts.

Branded revenue is expected to increase 11% in 2013, with a slight improvement in adjusted operating margin.

Goode now owns 17,000 shares.


Top Director Buys

Symphony International Holdings Ltd. (SIHL)
Amount purchased: 500,000 @ $0.78
Director name: Mr Anil Thadani
Value: $388,750

Symphony International Holdings Ltd. (SIHL)
Director name: Mr Anil Thadani
Amount purchased: 30,000 @ $0.76
Value: $22,800

Xchanging (XCH)
Director name: Mr Bill Thomas
Amount purchased: 14,289 @ 139.97p
Value: £20,000

Zotefoams (ZTF)
Director name: Ms Marie-Louise Clayton
Amount purchased: 8,000 @ 195.00p
Value: £15,600

JPMorgan Overseas Inv Trust (JMO)
Director name: Mr Jonathan Carey
Amount purchased: 1,500 @ 923.00p
Value: £13,845

JPMorgan Claverhouse Inv Trust (JCH)
Director name: Mr Andrew L Sutch
Amount purchased: 2,196 @ 521.39p
Value: £11,450


Top Director Sells

Sirius Minerals (SXX)
Director name: Mr Jason Murray
Amount sold: 2,166,667 @ 23.00p
Value: £498,333

Spectris (SXS)
Director name: Mr James Webster
Amount sold: 19,821 @ 2,129.31p
Value: £422,051

Hikma Pharmaceuticals (HIK)
Director name: Dr Ronald Goode
Amount sold: 5,700 @ 983.00p
Value: £56,031

NR

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Zotefoams Market Data

Currency UK Pounds
Share Price 400.00p
Change Today -8.00p
% Change -1.96 %
52 Week High 494.00
52 Week Low 360.00
Volume 7,883
Shares Issued 48.62m
Market Cap £194.48m
RiskGrade 186

Zotefoams Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.9% below the market average70.9% below the market average70.9% below the market average70.9% below the market average70.9% below the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average
Price Trend
77.26% below the market average77.26% below the market average77.26% below the market average77.26% below the market average77.26% below the market average
88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average
Income
57.77% below the market average57.77% below the market average57.77% below the market average57.77% below the market average57.77% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
1.69% above the market average1.69% above the market average1.69% above the market average1.69% above the market average1.69% above the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Zotefoams Dividends

  Latest Previous
  Interim Final
Ex-Div 09-Sep-21 06-May-21
Paid 08-Oct-21 01-Jun-21
Amount 2.10p 4.27p

Trades for 28-Sep-2021

Time Volume / Share Price
10:26 1,268 @ 396.29p
09:49 1,239 @ 401.00p
09:19 1,500 @ 394.62p
08:22 2,000 @ 400.00p
08:22 1,204 @ 401.00p

Zotefoams Key Personnel

CEO David Stirling
Finance Director Gary McGrath

Top of Page